They will study how sex-specific mechanisms involving Nox1 – a key source of ROS – and the satiety hormone, leptin – a key regulator of metabolism – impact endothelial cell metabolism and ...

Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research, Quebec, Canada (O.B., P.P., E.L.S.). Hypertension and Vascular Research Unit, Lady ...

Key Laboratory for Forest Resource Conservation and Utilization in the Southwest Mountains of China (Ministry of Education), College of Forestry, Southwest Forestry University, Kunming, China ...

Metabolic-associated fatty liver disease (MAFLD) is a new disease definition, and this nomenclature MAFLD was proposed to renovate its former name, non-alcoholic fatty liver disease (NAFLD).

BI 1015550 is an antifibrotic agent being developed by Boehringer Ingelheim. 9 The treatment is an oral phosphodiesterase 4 (PDE4) inhibitor 9 and has already completed a Phase 1 clinical trial ...

Department of Drug Chemistry and Technologies, Sapienza University of Rome, P.le Aldo Moro 5, Rome 00185, Italy ...